• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Biocon Ltd.
    09 Jan 2025
    340.65
    2.45%
    F&O Query: Should you hold Biocon put option?
    Business Line
    Copy LinkShare onShare on Share on Share on
    Biocon Ltd. has an average target of 389.25 from 4 brokers.
    logo
    AstraZeneca Pharma India Ltd.
    09 Jan 2025
    7940.50
    0.22%
    AstraZeneca and Merck drugs set to shake up treatment of liver cancer
    Business Standard
    Two late-stage studies published Wednesday in The Lancet show that Astra's Imfinzi and Merck's Keytruda delayed the progress of liver cancer when combined with other drugs and a local treatment
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above its 200 day SMA of 7313.5
    Astra, Merck Drugs Set to Shake Up Liver Cancer Treatment
    livemint | 09 Jan 2025
    logo
    Caplin Point Laboratories Ltd.
    09 Jan 2025
    High Gain High Volume
    2252.40
    5.90%
    Stock to buy today: Caplin Point Laboratories (2,580) BUY
    Business Line
    Caplin Point Laboratories shares can rise to 2,900-2,950
    Copy LinkShare onShare on Share on Share on
    Caplin Point Laboratories Ltd. is trading above all available SMAs
    Today's Stock Recommendation: January 9, 2025
    Business Line | 09 Jan 2025
    logo
    Mankind Pharma Ltd.
    08 Jan 2025
    2531.40
    -0.70%
    Complete Circle Capital's wealth management arm raises $3 million funding from Mankind Pharma promoters
    Complete Circle Capital's wealth management arm raises $3 million funding from Mankind Pharma promoters
    livemint
    Complete Circle Capital's wealth management division, established by Gurmeet Chadha and Kshitiz Mahajan in 2015, will utilize the funds to speed up its growth and expansion strategies.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. is trading above all available SMAs
    Mankind Pharma Pledges 56% Stake In Subsidiary Bharat Serums
    NDTV Profit | 07 Jan 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    08 Jan 2025
    1224.70
    0.04%
    Dr Reddy's share price jumps 4% on Nuvama's upgrade to buy; brokerage sees potential despite risks from Revlimid expiry
    Dr Reddy's share price jumps 4% on Nuvama's upgrade to buy; brokerage sees potential despite risks from Revlimid expiry
    livemint
    Dr Reddy's share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to 'Buy' with a target of 1,553, highlighting proactive strategies to mitigate the impact of Revlimid's patent expiration in 2026, despite a 9.35% drop in net profit for September 2024.
    Copy LinkShare onShare on Share on Share on
    KRChoksey increased Accumulate price target of Dr. Reddy's Laboratories Ltd. to 1324.0 on 13 May, 2025.
    Dr. Reddy's pops 4% after Nuvama upgrades to 'Buy'; arm sells US mfg unit
    Business Standard | 08 Jan 2025 1 more
    Dr. Reddy's Gets 'Buy' Upgrade From Nuvama On Plans To Mitigate Key Patent Loss
    NDTV Profit | 08 Jan 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    08 Jan 2025
    1224.70
    0.04%
    Markets fall on global cues; US jobs data dampens rate cut hopes
    Business Line
    While healthcare and energy stocks, such as Dr. Reddy's Laboratories and ONGC, showed resilience, companies like Trent faced notable losses.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr
    logo
    Alkem Laboratories Ltd.
    07 Jan 2025
    5374.00
    2.19%
    Alkem Laboratories To Sell Pithampur Unit For Rs 149 Crore
    Alkem Laboratories To Sell Pithampur Unit For Rs 149 Crore
    NDTV Profit
    The company has entered into a business transfer agreement with Rubicon Research Ltd. on Jan. 6, 2025, to sell the facility on a slump sale basis.
    Copy LinkShare onShare on Share on Share on
    Alkem Laboratories Ltd. is trading at high day volume of 209.5K.
    logo
    Laurus Labs Ltd.
    07 Jan 2025
    597.05
    0.64%
    Laurus Labs hits 2-yr high on hopes of healthy earnings; up 44% in 3 months
    Business Standard
    The board of directors of Laurus are scheduled to meet on January 24 to announce the financial results of the company for the quarter ended December 31, 2024.
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 34.27% in the last 1 Year
    logo
    Biocon Ltd.
    07 Jan 2025
    340.65
    2.45%
    Biocon stock zooms 9% on Psoriasis drug approval from Japan, Jefferies rating upgrade
    Biocon stock zooms 9% on Psoriasis drug approval from Japan, Jefferies rating upgrade
    livemint
    Biocon shares rose 9% to 389, driven by positive developments including Japanese approval for its biosimilar Ustekinumab. Jefferies upgraded its rating to 'Hold' with a target of 400, citing favorable FDA status for its Bengaluru facility.
    Copy LinkShare onShare on Share on Share on
    Biocon Ltd. is trading above its 50 day SMA of 332.4
    Biocon shares surge 7.79% on approval of Ustekinumab biosimilar in Japan
    Business Line | 07 Jan 2025 1 more
    Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug
    Business Standard | 07 Jan 2025
    logo
    Wockhardt Ltd.
    07 Jan 2025
    1341.20
    1.25%
    Wockhardt Eyes Rs 400-Crore Revenue From Pneumonia Antibiotic Miqnaf
    Wockhardt Eyes Rs 400-Crore Revenue From Pneumonia Antibiotic Miqnaf
    NDTV Profit
    Miqnaf is an antibiotic for treatment of community-acquired bacterial pneumonia, including those caused by multi-drug resistant pathogens.
    Copy LinkShare onShare on Share on Share on
    Promoters pledged 1.26% of shares in last quarter. Total pledge stands at 18.24% of promoter holdings
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd